HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Martek gains strength in patent lawsuit

This article was originally published in The Tan Sheet

Executive Summary

Martek Biosciences announces Nov. 1 a judge in the U.S. District Court for the District of Delaware will enter a permanent injunction against Lonza, Ltd., Nutrinova Inc. and Nutrinova Nutrition Specialties & Food Ingredients GmbH in a patent infringement suit. In October, a court in Dusseldorf, Germany made a verbal order in favor of DHA marketer Martek Biosciences in its European patent infringement lawsuit against Lonza (1"The Tan Sheet" Oct. 29, 2007, In Brief). The suit involves Lonza's U.S. sale of fatty acid product Lonza DHA for use in functional foods and dietary supplements. The U.S. judge upheld the October 2006 jury verdict that Lonza infringed on Martek's three patents (2"The Tan Sheet" Oct. 30, 2006, p. 13). Columbia, Md.-based Martek says it expects Lonza to appeal the decision to the U.S. Court of Appeals for the Federal Circuit. "The permanent injunction will be in effect pending any appeal," the firm says...

Related Content

Topics

UsernamePublicRestriction

Register

RS138780

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel